Sapphire Access Scheme expands to offer more patients reduced costs

Sapphire Clinics is offering 2,000 more patients the ability to access medical cannabis treatment at reduced costs.

Sapphire Clinics has announced the expansion of its award-winning access scheme, allowing more patients to contribute to the UK Medical Cannabis Registry.

The Sapphire Access Scheme, which launched in June 2020, offers discounted prices on consultation and prescription fees and is now open to additional 2,000 eligible patients.

Medical cannabis can be prescribed in the UK when deemed appropriate by specialist doctors where other treatment options have not provided adequate symptom relief. 

The UK Medical Cannabis Registry captures clinical outcomes and adverse events on all patients who are part of the scheme. In recognition of their contributions, patients gain additional insight into health tracking as well as significantly reduced appointment costs for the duration of their care.

Patients can now view their clinical outcome data in real time through the newly launched Sapphire Clinics webapp, allowing real time monitoring of their treatment.

To date, analysis from the registry has resulted in seven international peer-reviewed publications and 26 research abstracts presented at national and international medical research conferences.

Last year, the scheme was presented the ‘Bringing Treatment to the Masses’ award for the dedication to improving medical cannabis access. 

Dr Simon Erridge, head of research and access at Sapphire Clinics, commented: “We are pleased to be able to continue to extend the reduction in costs to access care as the research conducted at the clinics would not be possible without the support of the patients who participate.

“The work that we have published to date at Sapphire Medical Clinics ensures that the UK is leading the way with medical cannabis research and will be an important step in ensuring widened access for appropriate patients both in this country and internationally.”

Who is eligible for the Sapphire Access Scheme?

The next 2,000 patients eligible for treatment with medical cannabis at Sapphire Clinics who enrol onto the Sapphire Access Scheme can access the discounted prices below:

£50 – Initial Appointment

£50 – Monthly one follow-up appointment

£50 – Quarterly check-up appointment

£0 – Transfer patient appointment*

£0 – No repeat prescription fees

Find out more and complete the eligibility assessment online by clicking here.

*Patients who already have a prescription for medical cannabis from another cannabis clinic can transfer their care to Sapphire Clinics and will have their initial appointment fee waived until 31 December 2022. Complete the online eligibility application, selecting you are currently prescribed medical cannabis and email patientsupport@sapphireclinics.com to see if you are eligible for a free appointment.

• Grow Pharma apologises for price rises, blaming ‘escalating costs’
• Europe’s largest patient registry expands to offer more affordable access
• Provacan announces more discounts for CBD subscribers
• Over one million patients eligible for new medical cannabis exemption card
• Crowdfunder launched for key study into cost-benefits of cannabis on NHS